Home
3xper Innoventure (R&D)

3xper Innoventure (R&D) Market Share Analysis for August 2026

3xper offers integrated chemistry services for small molecule drug discovery, from hit ID to commercial supply, ensuring quality, cost-efficiency, and scalability.

Industry: N/A

Domain3xper.com

Year Founded2023

Employees51 - 200

Annual Revenue--

3xper Innoventure (R&D)

3xper Innoventure (R&D) (including company regionals)

3xper.com

See more website traffic and engagement information

Total visits to 3xper Innoventure (R&D)'s top domains

Understand 3xper Innoventure (R&D) market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

3xper.com1.4K

See more with Sales Intelligence

Avg. visit duration in 3xper Innoventure (R&D)'s top domains

Analyze 3xper Innoventure (R&D) engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

3xper.com00:01:51

See more with Sales Intelligence

Avg. pageviews on 3xper Innoventure (R&D)'s top domains

See how 3xper Innoventure (R&D) keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

3xper.com2.66

See more with Sales Intelligence

3xper Innoventure (R&D) top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by 3xper Innoventure (R&D)

These are the website technologies, by industry, used by 3xper Innoventure (R&D) top domains

Widget (7)

Twemoji

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from 3xper Innoventure (R&D)

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAnupam Rasayan India Limited partners with 3xper Innoventure Limited.Anupam Rasayan (NSE, BSE: ANURAS), one of India's leading custom synthesis & speciality chemicals manufacturer, inks Memorandum of Understanding (MoU) with 3xper Innoventure Limited, a subsidiary of Tube Investments of India Limited a leading business conglomerates of India for supply of targeted and identified new age pharma molecules.